Total sales were £63,433 in June, up 5% on May. Almost all of that growth came from advertising, as organic (non-ad) sales were flat at up 1%. The underlying business is steady rather than growing on its own.
The most important number in the account is the gap between the two figures above. A small slice of ad spend on brand terms returns £12 for every £1. The much larger spend aimed at new, non-brand customers returns about £1.20. The efficient advertising is defending sales you would likely win anyway, and June search data shows those brand terms already appear in close to 100% of relevant searches, so that demand is fully covered.
Zenutra is the growth engine and where the majority of focus is placed. It accounts for 61% of ad spend at a deliberate launch loss, and its Magnesium product reached the top ten in organic search during the month. Set Zenutra aside and the rest of the account runs at about 4% TACOS, comfortably inside the 10% target.
| June 2026 | Value | Month on month |
|---|---|---|
| Total sales | £63,433 | ▲ 5.0% |
| Organic sales | £50,808 | ▲ 1.2% |
| Advertising sales | £13,387 | ▲ 23.6% |
| Orders | 2,524 | ▲ 9.4% |
| Average order value | £25.13 | ▼ 4.0% |
Organic sales were £50,808, four fifths of the total, and up only 1%. Advertising sales were about £13,400, up 24%. June's growth was paid for with advertising rather than driven by underlying demand.
Orders rose 9% to 2,524 while units were broadly flat, and average order value fell 4% to £25.13, matching the Prime Day deal pricing run during the month. The business is stable and efficient. June's lift sat almost entirely on advertising, most of it the planned Zenutra launch.
Advertising cost 9.7% of total sales in June, just inside the 10% target. Around 11% of ad spend went on brand terms and returned 54% of all ad sales, at £12 back per £1. The other 89% chased non-brand demand and returned 46% of ad sales, at about £1.20 per £1. The efficient return the account shows is the brand protecting demand it already holds.
Zenutra accounts for 61% of all ad spend, at a deliberate launch loss. Set Zenutra aside and the rest of the account is efficient, with advertising at about 4% of sales.
Non-converting searches are negated continuously, so genuine wasted spend is minimal, around £66 in June. The remaining no-sale spend is deliberate Zenutra launch investment, spending into new terms to build ranking, plus higher Prime Day competition on terms that usually convert. This is normal early-stage and event activity, not overlooked waste.
Sales and advertising efficiency were steady through the first three weeks of June. Advertising cost rose in Prime Day week, 23 to 26 June, as spend was increased for the event and the Zenutra launch. This was expected and tied to the event rather than a change in the account.
Sales in the last few days of June ran below the earlier weeks, which can happen when a deal event pulls some demand forward. It is worth watching in July, but the effect is normal after a large deal event.
Brand searches, for example "udo's choice" and "cleanmarine", are efficient at £12 back per £1, but they defend demand you already have rather than bringing in new customers. June search data shows those brand searches already appear in almost every relevant search, close to 100% of the time, so that demand is already fully covered.
The new-customer searches that convert well are barely showing at all. Each of the terms below converts efficiently yet appears in under 5% of the searches it could. This is where the real growth room sits, and where investment should now go.
| Non-brand term | Return per £1 | Share of searches shown |
|---|---|---|
| Digestive enzymes | £7.70 | 0.2% |
| Omega 3 6 9 capsules | £10.00 | 0.3% |
| Krill oil | £4.20 | 4.4% |
Searches that stop converting are negated on an ongoing basis, so little spend sits on dead terms.
Turned £214 of spend into £2,897 of sales across 111 orders. Efficient and well established, defending the brand’s core demand. The Udo's Enzymes and Krill Oil campaigns also ran efficiently through the month.
Spent £59 for £17 of sales. It was paused during June and is being rebuilt.
Underperforming search terms were negated and low-value campaigns paused during the month, keeping spend focused on the terms and products that convert. The efficient campaigns defend the brand, and that base is well covered. The clear next step is to build campaigns around the small set of non-brand searches that already convert well, where new-customer growth will come from.
Udo's Choice remains the core of the account. Its listings convert well and its brand-defence advertising is efficient. The main Enzymes listing wins the Buy Box 84% of the time and is worth lifting above 90% before spending more on it.
Eye Logic Dry Eye Spray had 676 visits but won the Buy Box only 48% of the time and converted just over 1 in 10 visitors. This is a problem with the listing and Buy Box rather than a shortage of traffic. Ad spend on it was held back in June while both are addressed.
Cleanmarine MenoMin drew 263 visits and £1,476 of sales. Its advertising ran at a heavy loss, so it was pulled back during June. Krill Oil advertising ran efficiently, though nearly all of it comes from brand searches rather than new-customer demand.
Manuka Health listings won the Buy Box between 75% and 77% of the time in June, linked to overseas resellers competing on price. Transparency is launching shortly on Manuka Health, which will remove these resellers and resolve the Buy Box issue at source.
Zenutra, reported separately as a launch, generated £5,536 of sales at a planned launch loss. Its main Magnesium product climbed the organic search rankings during June, reaching the top ten for "magnesium bisglycinate", a good early sign for a product three months into launch.